Looking to publish in Molecular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginMolecular Therapy is a peer-reviewed journal focused on gene transfer, vector development and design, stem cell manipulation, gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics, vaccine development, pre-clinical target validation, safety and efficacy studies, and clinical trials. It publishes research, reviews, and commentaries in genetics, medicine, and biotechnology and is published for the American Society for Gene and Cell Therapy by Elsevier.
Looking to publish in Molecular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Molecular Therapy accepts the following article types. Click on an article type to view submission instructions.
Original Research Article
Review Article
Brief Report
Case Report
Letter To The Editor
Recent Publications
Closed-loop inhibitory metabotropic glutamate receptor gene therapy for focal refractory epilepsy
Laura V. Ussingkær, Dimitri M. Kullmann
A Scalable, Antibody-Free Lipid Nanoparticle Achieves Preferential mRNA Delivery to Human HSPCs In Vivo Without Conditioning
Eunyoung Kim, Ryan Zenhausern, Shivani Kapadia, Sylvanie Johnson, Skylar Cho, Joanne Choi, Kernyu Park, Edgard Diaz, Ananda R. Podilapu, Ramachandran Kuppan, James E. Dahlman, Hyejin Kim, Janghee Woo
CochleaNet: deep learning-based image analysis for cochlear connectomics and gene therapy
Lennart Roos, Aleyna Miraç Diniz, Elisabeth Koert, Martin Schilling, Mara Uhl, Anupriya Thirumalai, Mostafa Aakhte, Kathrin Kusch, Jan Huisken, Tobias Moser, Constantin Pape
Least but not last: Durable C5 silencing for IgA nephropathy
Davide D'Onghia, Annalisa Di Ruscio
Frequently asked questions
How long does it take to publish?
Median 136 days from submission to acceptance decision for accepted papers.
Reformat to Molecular Therapy using Livewrite PremiumIs a cover letter required?
A cover letter is required on institutional letterhead. It should explain the conceptual advance and relevance to readers and include information relevant to handling and evaluation of the paper, such as related work, time constraints, competition, and any declared conflicts of interest.
Reformat to Molecular Therapy using Livewrite PremiumWhat are the publication costs?
Open access APC is USD 4,500 excluding taxes. Subscription publication has no publication fee charged to authors.
Reformat to Molecular Therapy using Livewrite Premium